Abstract:Fibroblast growth factor 21 (FGF-21) is a member of FGF family. Recently, it is discovered as a non-insulin-dependent cytokine to regulate blood glucose and a potential drug candidate for treatment of type 2 diabetes mellitus. However, the stability of FGF-21 is poor and its half-life in vivo is short, which severely affect its application in clinical practice. In order to solve this problem, the N-terminus of mFGF-21 was PEGylated in a site-specific manner by methoxy poly-ethylene glycol (mPEG) propionaldehydes with an average molecular mass of 20 ku for improving its biological properties including increasing half-life in vivo, and decreasing immunogenicity. The effects of pH, reaction time, protein concentrations and mass ratio between the reactants on the PEGylation of mFGF-21 were analyzed. PEG-mFGF-21 was isolated by Capto Q anion exchange chromatography or Superdex 75 gel filtration chromatography. As a result, the optimal reaction, method for mFGF-21 PEGylation and purification processes of PEG-mFGF-21 were established. Then we study the physical and chemical properties, immunogenicity, in vivo half-life, in vitro biological activity and in vivo hypoglycemic effects of PEG-mFGF-21. We found that the temperature stability and anti-protease ability of mFGF-21 were significantly improved after PEGylation. The indirect ELISA results for detection of serum antibody levels against mFGF-21 and the target protein concentration showed that PEGlyation of mFGF-21 significantly reduced its immunogenicity and increased its half-life in vivo. The glucose uptake assay results in HepG2 cells demonstrated that the in vitro activity of PEG-mFGF-21 did not decline. However, with the increment of stimulating time, the glucose uptake in cells treated with PEG-mFGF-21 significantly increased than mFGF-21. The experimental results of short-term blood glucose regulation in type 2 diabetic animals showed that the hypoglycemic speed of mFGF-21 was faster than PEG-mFGF-21, but it lasted shorter. The long-term blood glucose regulation experimental results showed that PEG-mFGF-21 had better hypoglycemic effect than mFGF-21. Surprisingly, blood glucose of PEG-mFGF-21-treated mice remained at low level for several days after the drug was withdrawn. In conclusion, under the premise of remaining its biological activity in vitro, PEGylation of mFGF-21 can improve its physical stability and anti-protease ability, decrease its immunogenicity and increase its in vivo half-life. It can also prolong the hypoglycemic effect of mFGF-21 in diabetic animals. This study provides an important technology platform for drug development of FGF-21.

Study on PEGylation of Recombinant Keratinocyte Growth Factor-I and Activity in Vitro

Chemical Modification of Recombinant Human Keratinocyte Growth Factor 2 with Polyethylene Glycol Improves Biostability and Reduces Animal Immunogenicity

Site-directed PEGylation of human basic fibroblast growth factor.

Expression, Purification and Activity Detemination of Recombinant Human Keratinocyte Growth Factor in Pichia Pastoris

Site-Directed Chemical Modification of Recombinant Human Afgf Mutant with Polyethylene Glycol

haFGF Mutant Site-directed Modified by PEG

The Hypoglycemic Effect of the Pegylated Fgf-21

Condition Optimization for Modification of Recombinant Human Ciliary Neurotrophic Factor with Polythylene Glycol

Expression,purification and PEGylation of recombinant human ciliary neurotrophic factor

Enhanced protection of modified human acidic fibroblast growth factor with polyethylene glycol against ischemia/reperfusion-induced retinal damage in rats

Studies of poly(ethylene glycol) modification of HM-3 polypeptides.

Studies on the Pegylation of Protein at A Specific Site: Sulfhydryl-Pegylation of 97Cys-Ifn-gamma

Study on Pegylation of Antineoplasm Metastatic Poly-Beta Peptide

Combined Optimization of N-terminal Site-Specific PEGylation of Recombinant Hirudin Using Response Surface Methodology and Kinetic Analysis.

In Vivo Pharmacokinetics, Immunogenicity and Mechanism of PEGylated Antitumor Polypeptide

Mpegylation of Insulin and Characterization of Its Activity

[Construction of Keratinocyte Growth Factor Phage Active Peptides for the Promotion of Epidermal Cell Proliferation].

A Better Anti-Diabetic Recombinant Human Fibroblast Growth Factor 21 (Rhfgf21) Modified With Polyethylene Glycol

[Study of Target Pegylated Recombinant Mutant Human Granulocyte Colony Stimulating Factor].

PEGylation of Ginsenoside Rg3-Entrapped Bovine Serum Albumin Nanoparticles: Preparation, Characterization, and In Vitro Biological Studies

In silico analysis of different signal peptides for the secretory production of recombinant human keratinocyte growth factor in Escherichia coli